Study: Sclerotherapy with Polidocanol in children with inter
Researchers retrospectively reviewed children who underwent sclerotherapy for internal hemorrhoids, and analyzed patients characteristics and outcomes. Hemorrhoids are an extremely rare condition in children, and data on its incidence and treatment in the pediatric population remains scarce.

A total of 14 pediatric sclerotherapy patients were included in the study. The association between age and sclerosant volume, as well as the required dose of polidocanol based on the grade of hemorrhoids, were statistically evaluated.

--Patients had a male predominance with a ratio of 2.5:1 (grade 2:6 patients, grade 3:8 patients).

--4 children had underlying conditions including portal hypertension and Klippel–Trenaunay syndrome.

--Of the 14 patients, 43% had constipation requiring medication or enema. Only one minor complication, a perianal ulceration, was found to be associated with sclerotherapy.

--Patients with grade 3 hemorrhoids required a significantly larger amount of polidocanol than those with grade 2 hemorrhoids.

--2 patients with grade 3 hemorrhoids required a second session of treatment for recurrence. The success rate of sclerotherapy with polidocanol was 86%.

To summarize, polidocanol sclerotherapy is a safe, effective, and less intrusive treatment alternative for internal hemorrhoids in children.